Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Vanessa Martins, Lynsey Fazal, Aram Oganesian, Alpesh Shah, Jessie Stow, Hugh Walton & Nicola Wilsher. (2022) A commentary on the use of pharmacoenhancers in the pharmaceutical industry and the implication for DMPK drug discovery strategies. Xenobiotica 52:8, pages 786-796.
Read now
Read now
Santosh Kumar Sreevatsav Adiraju, Kiran Shekar, John F. Fraser, Maree T. Smith & Sussan Ghassabian. (2018) Effect of cardiopulmonary bypass on cytochrome P450 enzyme activity: implications for pharmacotherapy. Drug Metabolism Reviews 50:2, pages 109-124.
Read now
Read now
Honghui Zhou & Amarnath Sharma. (2016) Therapeutic protein-drug interactions: plausible mechanisms and assessment strategies. Expert Opinion on Drug Metabolism & Toxicology 12:11, pages 1323-1331.
Read now
Read now
Sabine Gerbal-Chaloin, Irena Iankova, Patrick Maurel & Martine Daujat-Chavanieu. (2013) Nuclear receptors in the cross-talk of drug metabolism and inflammation. Drug Metabolism Reviews 45:1, pages 122-144.
Read now
Read now
Alexander M Cressman, Vanja Petrovic & Micheline Piquette-Miller. (2012) Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug response. Expert Review of Clinical Pharmacology 5:1, pages 69-89.
Read now
Read now
Satyanarayana R Pondugula, Hanqing Dong & Taosheng Chen. (2009) Phosphorylation and protein–protein interactions in PXR-mediated CYP3A repression. Expert Opinion on Drug Metabolism & Toxicology 5:8, pages 861-873.
Read now
Read now
Guillaume Dumais, Mirela Iovu & Patrick du Souich. (2008) Inflammatory reactions and drug response: importance of cytochrome P450 and membrane transporters. Expert Review of Clinical Pharmacology 1:5, pages 627-647.
Read now
Read now
Articles from other publishers (63)
Wenming Jia, Shuai Chen, Ran Wei, Xiaoqi Yang, Minfa Zhang, Ye Qian, Heng Liu & Dapeng Lei. (2023) CYP4F12 is a potential biomarker and inhibits cell migration of head and neck squamous cell carcinoma via EMT pathway. Scientific Reports 13:1.
Crossref
Crossref
Fengling Wang, Xue Zhang, Yanyan Wang, Yunna Chen, Huiyu Lu, Xiangyun Meng, Xi Ye & Weidong Chen. (2023) Activation/Inactivation of Anticancer Drugs by CYP3A4: Influencing Factors for Personalized Cancer Therapy. Drug Metabolism and Disposition 51:5, pages 543-559.
Crossref
Crossref
Shaghayegh Mohsenian Naghani, Mark MPM Jansen, Tessa Jaspers, Diane Bastiaans & David Burger. (2023) Crushing lopinavir/ritonavir tablets does not result in lower exposure to lopinavir/ritonavir in adult patients with COVID-19. European Journal of Hospital Pharmacy 30:e1, pages e106-e108.
Crossref
Crossref
Alican Özkan, Danielle L. Stolley, Erik N. K. Cressman, Matthew McMillin, Thomas E. Yankeelov & Marissa Nichole Rylander. (2023) Vascularized Hepatocellular Carcinoma on a Chip to Control Chemoresistance through Cirrhosis, Inflammation and Metabolic Activity. Small Structures.
Crossref
Crossref
Samuel J.I. Blackford, Tracy T.L. Yu, Michael D.A. Norman, Adam M. Syanda, Michail Manolakakis, Dariusz Lachowski, Ziqian Yan, Yunzhe Guo, Elena Garitta, Federica Riccio, Geraldine M. Jowett, Soon Seng Ng, Santiago Vernia, Armando E. del Río Hernández, Eileen Gentleman & S. Tamir Rashid. (2023) RGD density along with substrate stiffness regulate hPSC hepatocyte functionality through YAP signalling. Biomaterials 293, pages 121982.
Crossref
Crossref
Hossein Sadeghi, Veys Hashemnia, Ehsan Nazemalhosseini-Mojarad, Mohammad Reza Ghasemi & Reza Mirfakhraie. (2022) Correlated downregulation of VDR and CYP3A4 in colorectal cancer. Molecular Biology Reports 50:2, pages 1385-1391.
Crossref
Crossref
Borislav Angelov, Emilio Mateev, Maya Georgieva, Virginia Tzankova & Magdalena Kondeva-Burdina. (2022) In vitro effects and in silico analysis of newly synthetized pyrrole derivatives on the activity of different isoforms of Cytochrome P450: CYP1A2, CYP2D6 and CYP3A4. Pharmacia 69:4, pages 1013-1017.
Crossref
Crossref
Alberto Aragón-Muriel, Bethsy A. Aguilar-Castillo, Ernesto Rufino-Felipe, Hugo Valdés, Lucero González-Sebastián, Rebeca Nayely Osorio-Yáñez, Yamil Liscano, Valente Gómez-Benítez, Dorian Polo-Cerón & David Morales-Morales. (2022) Antibacterial activity and molecular studies of non-symmetric POCOP-Pd(II) pincer complexes derived from 2,4-dihydroxybenzaldehyde (2,4-DHBA). Polyhedron 227, pages 116115.
Crossref
Crossref
Lyubov S. Klyushova, Maria L. Perepechaeva & Alevtina Y. Grishanova. (2022) The Role of CYP3A in Health and Disease. Biomedicines 10:11, pages 2686.
Crossref
Crossref
Shuaijun Lu, Yang Li, Changling Zhu, Weihua Wang & Yuping Zhou. (2022) Managing Cancer Drug Resistance from the Perspective of Inflammation. Journal of Oncology 2022, pages 1-13.
Crossref
Crossref
Takahiro Sumimoto, Ryosuke NakaharaYosuke Suzuki, Ryota TanakaNatsumi YoshidaMasao OgataHiroki Itoh. (2022) Development of a Sensitive and High-Throughput Assay for Simultaneous Quantification of 5 Tyrosine Kinase Inhibitors and 2 Active Metabolites in Human Plasma Using Ultra-high Performance Liquid Chromatography Coupled to Tandem Mass Spectrometry. Therapeutic Drug Monitoring 44:3, pages 419-429.
Crossref
Crossref
Yusra Habib Khan, Nida Bokharee, Maria Rasheed, Amna Saifullah, Aisha Khokhar, Safia Akhtar Khan, Amjad Khan & Tauqeer Hussain Mallhi. 2022. Biochemistry of Drug Metabolizing Enzymes. Biochemistry of Drug Metabolizing Enzymes
141
159
.
Azka Yaqoob, Qudsia Rehman, Kanwal Rehman, Muhammad Sajid Hamid Akash, Iqbal Hussain & Rasheed Ahmad. 2022. Biochemistry of Drug Metabolizing Enzymes. Biochemistry of Drug Metabolizing Enzymes
73
108
.
Camille Lenoir, Victoria Rollason, Jules A. Desmeules & Caroline F. Samer. (2021) Influence of Inflammation on Cytochromes P450 Activity in Adults: A Systematic Review of the Literature. Frontiers in Pharmacology 12.
Crossref
Crossref
Helena Bergström, Maria Helde Frankling, Caritha Klasson, Anita Lövgren Sandblom, Ulf Diczfalusy & Linda Björkhem-Bergman. (2021) CYP3A Activity in End-of-Life Cancer Patients Measured by 4β-Hydroxycholesterol/cholesterol Ratio, in Men and Women. Cancers 13:18, pages 4689.
Crossref
Crossref
Lucy Darakjian, Malavika Deodhar, Jacques Turgeon & Veronique Michaud. (2021) Chronic Inflammatory Status Observed in Patients with Type 2 Diabetes Induces Modulation of Cytochrome P450 Expression and Activity. International Journal of Molecular Sciences 22:9, pages 4967.
Crossref
Crossref
Rebekah L. I. Crake, Matthew R. Strother, Elisabeth Phillips, Matthew P. Doogue, Mei Zhang, Chris M. A. Frampton, Bridget A. Robinson & Margaret J. Currie. (2021) Influence of serum inflammatory cytokines on cytochrome P450 drug metabolising activity during breast cancer chemotherapy: a patient feasibility study. Scientific Reports 11:1.
Crossref
Crossref
Stéphanie M. L. M. Looijaard, Miriam L. Lintel Hekkert, Rob C. I. Wüst, René H. J. Otten, Carel G. M. Meskers & Andrea B. Maier. (2020) Pathophysiological mechanisms explaining poor clinical outcome of older cancer patients with low skeletal muscle mass. Acta Physiologica 231:1.
Crossref
Crossref
Haiqing Isaac Dai, Yulia Vugmeyster & Naveen Mangal. (2020) Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno‐Oncology and Beyond: Challenges, Perspectives, and Prospects. Clinical Pharmacology & Therapeutics 108:6, pages 1156-1170.
Crossref
Crossref
Soledad Henriquez, Bertrand Dunogué, Raphael Porcher, Alexis Régent, Pascal Cohen, Alice Berezne, Sami Kolta, Claire Le Jeunne, Luc Mouthon, Christian Roux, Loïc Guillevin, Karine Briot & Benjamin Terrier. (2020) Handgrip strength is a comorbidity marker in systemic necrotizing vasculitides and predicts the risk of fracture and serious adverse events. Rheumatology 59:9, pages 2581-2590.
Crossref
Crossref
Benjamin D. W. Harris, Viet Phan, Vidya Perera, Anneliese Szyc, Peter Galettis, Jennifer H. Martin, Euan Walpole, Andrew J. McLachlan, Stephen J. Clarke, Stephanie E. Reuter & Kellie A. Charles. (2020) Inability of Current Dosing to Achieve Carboplatin Therapeutic Targets in People with Advanced Non-Small Cell Lung Cancer: Impact of Systemic Inflammation on Carboplatin Exposure and Clinical Outcomes. Clinical Pharmacokinetics 59:8, pages 1013-1026.
Crossref
Crossref
Jiali Liu, Xiaoliang Jin, Fang Zhou, Hongzhu Chen, Wenjie Wang, Yan Liu, Guangji Wang, Kun Hao & Jingwei Zhang. (2020) Disrupted hepatic pentose phosphate pathway directly participates in and indirectly promotes CYP3A reduction: A new strategy for CYP3A‐mediated drug hepatotoxicity. British Journal of Pharmacology 177:7, pages 1538-1555.
Crossref
Crossref
Kei Mayumi, Takanori Akazawa, Takushi Kanazu, Shuichi Ohnishi & Hiroshi Hasegawa. (2020) Successful Prediction of Human Pharmacokinetics After Oral Administration by Optimized Physiologically Based Pharmacokinetics Approach and Permeation Assay Using Human Induced Pluripotent Stem Cell–Derived Intestinal Epithelial Cells. Journal of Pharmaceutical Sciences 109:4, pages 1605-1614.
Crossref
Crossref
Chuanzhu Lv & Ling Huang. (2020) Xenobiotic receptors in mediating the effect of sepsis on drug metabolism. Acta Pharmaceutica Sinica B 10:1, pages 33-41.
Crossref
Crossref
Ali N. Chamseddine, Michel Ducreux, Jean-Pierre Armand, Xavier Paoletti, Tuvana Satar, Angelo Paci & Olivier Mir. (2019) Intestinal bacterial β-glucuronidase as a possible predictive biomarker of irinotecan-induced diarrhea severity. Pharmacology & Therapeutics 199, pages 1-15.
Crossref
Crossref
Meng Su, Yu‐Ting Chang, Daniela Hernandez, Richard J. Jones & Gabriel Ghiaur. (2019) Regulation of drug metabolizing enzymes in the leukaemic bone marrow microenvironment. Journal of Cellular and Molecular Medicine 23:6, pages 4111-4117.
Crossref
Crossref
Hiroki Ishihara, Toshio Takagi, Tsunenori Kondo, Hironori Fukuda, Kazuhiko Yoshida, Junpei Iizuka & Kazunari Tanabe. (2018) Effect of Changes in Skeletal Muscle Mass on Oncological Outcomes During First-Line Sunitinib Therapy for Metastatic Renal Cell Carcinoma. Targeted Oncology 13:6, pages 745-755.
Crossref
Crossref
Atsushi Kawase, Shunsuke Tateishi & Akira Kazaoka. (2018) Profiling of hepatic metabolizing enzymes and nuclear receptors in rats with adjuvant arthritis by targeted proteomics. Biopharmaceutics & Drug Disposition 39:6, pages 308-314.
Crossref
Crossref
Elisavet Stavropoulou, Gratiela G. Pircalabioru & Eugenia Bezirtzoglou. (2018) The Role of Cytochromes P450 in Infection. Frontiers in Immunology 9.
Crossref
Crossref
Kerry B. Goralski, Matthew A. Ladda & Jenna O. McNeil. 2018. Drug Interactions in Infectious Diseases: Mechanisms and Models of Drug Interactions. Drug Interactions in Infectious Diseases: Mechanisms and Models of Drug Interactions
163
204
.
Priya Patel, J. Steven Leeder, Micheline Piquette-Miller & L. Lee Dupuis. (2017) Aprepitant and fosaprepitant drug interactions: a systematic review. British Journal of Clinical Pharmacology 83:10, pages 2148-2162.
Crossref
Crossref
Jeff L. Staudinger. 2017. SUMO Regulation of Cellular Processes. SUMO Regulation of Cellular Processes
99
110
.
Ting-Yao Wang, Wei-Ming Chen, Lan-Yan Yang, Chao-Yu Chen, Wen-Chi Chou, Yi-Yang Chen, Chih-Cheng Chen, Kuan-Der Lee & Chang-Hsien Lu. (2016) Score of liver ultrasonography predicts treatment-related severe neutropenia and neutropenic fever in induction chemotherapy with docetaxel for locally advanced head and neck cancer patients with normal serum transamines. Supportive Care in Cancer 24:11, pages 4697-4703.
Crossref
Crossref
Hiroki Ishihara, Tsunenori Kondo, Kenji Omae, Toshio Takagi, Jumpei Iizuka, Hirohito Kobayashi & Kazunari Tanabe. (2016) Sarcopenia and the Modified Glasgow Prognostic Score are Significant Predictors of Survival Among Patients with Metastatic Renal Cell Carcinoma Who are Receiving First-Line Sunitinib Treatment. Targeted Oncology 11:5, pages 605-617.
Crossref
Crossref
James B. Mangold, Fan Wu & Sam Rebello. (2016) Compelling Relationship of CYP3A Induction to Levels of the Putative Biomarker 4β-Hydroxycholesterol and Changes in Midazolam Exposure. Clinical Pharmacology in Drug Development 5:4, pages 245-249.
Crossref
Crossref
Ramy El-Sayed, Kunal Bhattacharya, Zonglin Gu, Zaixing Yang, Jeffrey K. Weber, Hu Li, Klaus Leifer, Yichen Zhao, Muhammet S. Toprak, Ruhong Zhou & Bengt Fadeel. (2016) Single-Walled Carbon Nanotubes Inhibit the Cytochrome P450 Enzyme, CYP3A4. Scientific Reports 6:1.
Crossref
Crossref
Yuko Kanbayashi, Toyoshi HosokawaKohichiroh Yasui, Fumiya Hongo, Kanji Yamaguchi, Michihisa Moriguchi, Tsuneharu Miki & Yoshito Itoh. (2016) Predictive factors for sorafenib-induced hand–foot skin reaction using ordered logistic regression analysis. American Journal of Health-System Pharmacy 73:1, pages e18-e23.
Crossref
Crossref
Frédérick Moryoussef, Marion Dhooge, Julien Volet, Coralie Barbe, Catherine Brezault, Christine Hoeffel, Romain Coriat & Olivier Bouché. (2015) Reversible sarcopenia in patients with gastrointestinal stromal tumor treated with imatinib. Journal of Cachexia, Sarcopenia and Muscle 6:4, pages 343-350.
Crossref
Crossref
Annemieke J.M. Nieuweboer, Ellen S. de Morrée, Anne-Joy M. de Graan, Alex Sparreboom, Ronald de Wit & Ron H.J. Mathijssen. (2015) Inter-patient variability in docetaxel pharmacokinetics: A review. Cancer Treatment Reviews 41:7, pages 605-613.
Crossref
Crossref
DE Coutant, P Kulanthaivel, PK Turner, RL Bell, J Baldwin, SR Wijayawardana, C Pitou & SD Hall. (2015) Understanding Disease–Drug Interactions in Cancer Patients: Implications for Dosing Within the Therapeutic Window. Clinical Pharmacology & Therapeutics 98:1, pages 76-86.
Crossref
Crossref
Connie I. Diakos, Kellie A. Charles, Wei Chua, Viive M. Howell & Stephen J. Clarke. 2015. Biomarkers in Cancer. Biomarkers in Cancer
601
629
.
R Donald Harvey & E T Morgan. (2014) Cancer, Inflammation, and Therapy: Effects on Cytochrome P450–Mediated Drug Metabolism and Implications for Novel Immunotherapeutic Agents. Clinical Pharmacology & Therapeutics 96:4, pages 449-457.
Crossref
Crossref
C S D Roxburgh & D C McMillan. (2014) Cancer and systemic inflammation: treat the tumour and treat the host. British Journal of Cancer 110:6, pages 1409-1412.
Crossref
Crossref
Connie I. Diakos, Kellie A. Charles, Wei Chua, Viive M. Howell & Stephen J. Clarke. 2014. Biomarkers in Cancer. Biomarkers in Cancer
1
25
.
P. N. Morcos, S. A. Moreira, B. J. Brennan, S. Blotner, N. S. Shulman & P. F. Smith. (2013) Influence of chronic hepatitis C infection on cytochrome P450 3a4 activity using midazolam as an in vivo probe substrate. European Journal of Clinical Pharmacology 69:10, pages 1777-1784.
Crossref
Crossref
Marina Kacevska, Andre Mahns, Rohini Sharma, Stephen J. Clarke, Graham R. Robertson & Christopher Liddle. (2013) Extra-Hepatic Cancer Represses Hepatic Drug Metabolism Via Interleukin (IL)-6 Signalling. Pharmaceutical Research 30:9, pages 2270-2278.
Crossref
Crossref
Connie I Diakos, Wei Chua, Kellie A Charles, Viive M Howell & Stephen J Clarke. (2013) Predicting chemotherapeutic response and toxicity in colorectal cancer. Colorectal Cancer 2:4, pages 333-345.
Crossref
Crossref
Alexander Liberman, Zhe Wu, Christopher V. Barback, Robert Viveros, Sarah L. Blair, Lesley G. Ellies, David R. Vera, Robert F. Mattrey, Andrew C. Kummel & William C. Trogler. (2013) Color Doppler Ultrasound and Gamma Imaging of Intratumorally Injected 500 nm Iron–Silica Nanoshells. ACS Nano 7:7, pages 6367-6377.
Crossref
Crossref
Johannes J. Moes, Frederik E. Stuurman, Jeroen J.M.A. Hendrikx, Serena Marchetti, Alwin D.R. Huitema, Jos H. Beijnen, Jan H.M. Schellens & Bastiaan Nuijen. (2013) Pharmacokinetic evaluation of three oral formulations of docetaxel boosted with ritonavir: two single-drug formulations vs. a fixed-dose combination tablet. Drug Delivery and Translational Research 3:3, pages 243-251.
Crossref
Crossref
Ibrahim Ince, Saskia N. de Wildt, Mariska Y.M. Peeters, Daryl J. Murry, Dick Tibboel, Meindert Danhof & Catherijne A.J. Knibbe. (2012) Critical Illness Is a Major Determinant of Midazolam Clearance in Children Aged 1 Month to 17 Years. Therapeutic Drug Monitoring 34:4, pages 381-389.
Crossref
Crossref
Olivier Mir, Romain Coriat, Benoit Blanchet, Jean-Philippe Durand, Pascaline Boudou-Rouquette, Judith Michels, Stanislas Ropert, Michel Vidal, Stanislas Pol, Stanislas Chaussade & François Goldwasser. (2012) Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma. PLoS ONE 7:5, pages e37563.
Crossref
Crossref
Hadi Molanaei, Peter Stenvinkel, Abdul Rashid Qureshi, Juan Jesús Carrero, Olof Heimbürger, Bengt Lindholm, Ulf Diczfalusy, Ingegerd Odar-Cederlöf & Leif Bertilsson. (2011) Metabolism of alprazolam (a marker of CYP3A4) in hemodialysis patients with persistent inflammation. European Journal of Clinical Pharmacology 68:5, pages 571-577.
Crossref
Crossref
Kevin L. Salyers & Yang Xu. 2012. ADME‐Enabling Technologies in Drug Design and Development. ADME‐Enabling Technologies in Drug Design and Development
253
276
.
Zdenek Dvorak. 2012. Metabolism of Drugs and Other Xenobiotics. Metabolism of Drugs and Other Xenobiotics
223
258
.
Alexander V. LyubimovEdward T. Morgan, Choon‐Myung Lee & Beatrice A. Nyagode. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
45
.
Albert Lee, Joel M. Chick, Daniel Kolarich, Paul A. Haynes, Graham R. Robertson, Maria Tsoli, Lucy Jankova, Stephen J. Clarke, Nicolle H. Packer & Mark S. Baker. (2011) Liver Membrane Proteome Glycosylation Changes in Mice Bearing an Extra-hepatic Tumor. Molecular & Cellular Proteomics 10:9, pages M900538-MCP200.
Crossref
Crossref
Marina Kacevska, Michael R. Downes, Rohini Sharma, Ronald M. Evans, Stephen J. Clarke, Christopher Liddle & Graham R. Robertson. (2011) Extrahepatic Cancer Suppresses Nuclear Receptor–Regulated Drug Metabolism. Clinical Cancer Research 17:10, pages 3170-3180.
Crossref
Crossref
Jenna O. McNeil & Kerry B. Goralski. 2011. Drug Interactions in Infectious Diseases. Drug Interactions in Infectious Diseases
167
201
.
C. S. D. Roxburgh, A. M. Wallace, G. K. Guthrie, P. G. Horgan & D. C. McMillan. (2009) Comparison of the prognostic value of tumour‐ and patient‐related factors in patients undergoing potentially curative surgery for colon cancer. Colorectal Disease 12:10, pages 987-994.
Crossref
Crossref
Zhang Hong, Fang Yu, Li Ying & Liang Aibin. (2010) A highly sensitive SPE- liquid/liquid extraction – RPLC analytical method for the determination of 6β-hydroxycortisol and cortisol in cancer patients' urine. Journal of Medical Colleges of PLA 25:2, pages 75-83.
Crossref
Crossref
Michiko Sugawara, Kiyoshi Okamoto, Tadashi Kadowaki, Kazutomi Kusano, Akiyoshi Fukamizu & Tsutomu Yoshimura. (2010) Expressions of Cytochrome P450, UDP-Glucuronosyltranferase, and Transporter Genes in Monolayer Carcinoma Cells Change in Subcutaneous Tumors Grown As Xenografts in Immunodeficient Nude Mice. Drug Metabolism and Disposition 38:3, pages 526-533.
Crossref
Crossref
ET Morgan. (2009) Impact of Infectious and Inflammatory Disease on Cytochrome P450–Mediated Drug Metabolism and Pharmacokinetics. Clinical Pharmacology & Therapeutics 85:4, pages 434-438.
Crossref
Crossref
Yuki Izuwa, Jun-ichi Kusaba, Mizuki Horiuchi, Tetsuya Aiba, Hiromu Kawasaki & Yuji Kurosaki. (2009) Comparative Study of Increased Plasma Quinidine Concentration in Rats with Glyceroland Cisplatin-induced Acute Renal Failure. Drug Metabolism and Pharmacokinetics 24:5, pages 451-457.
Crossref
Crossref